Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.gujaratinject.in | |
Market Cap | 11.79 Cr. | |
Enterprise Value(EV) | 12.40 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.04 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 240.67 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.15 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 4.98 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 2.10 | Calculated using Price: 10.43 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.13 Cr. | 11,306,500 Shares |
FaceValue | 10 | |
About Gujarat Inject (Kerala) Ltd. | ||
Gujarat Inject (Kerala) (GKIL) was incorporated on January 7, 1991 and obtained certificate for commencement of business on February 14, 1991. The company has been jointly promoted by the Kerala State Industrial Development Corporation (KSIDC), a wholly owned subsidiary of Government of Kerala undertaking and Gujarat Inject (GIL) and its associates. The company has received SIA registration to manufacture intravenous solutions at puddussey east, kanjikode, in palghat district in Kerala. |
1 Day |
|
-4.60% |
1 Week |
|
-18.44% |
1 Month |
|
-26.41% |
3 Month |
|
-23.46% |
6 Month |
|
+10.19% |
1 Year |
|
+31.96% |
2 Year |
|
|
5 Year |
|
|
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Return on Capital Employed (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Return on Assets (%) | -1.84 | 1373.74 | 6.93 | -102.49 | -30.2 | 1.57 | -664.44 | 5.37 | 22.31 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | -3 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |
Minority Int. | |||||||||||
Equity & Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Non Curr. Assets | 0 | 0 | 0 | ||||||||
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 0 | 2 | 0 | 0 | 0 | 0 | |||||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Total Income | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||
Total Expenditure | 0 | -2 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | ||
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Interest | |||||||||||
Depreciation | |||||||||||
Taxation | 0 | 0 | |||||||||
Exceptional Items | 2 | ||||||||||
PAT | 2 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Adjusted EPS | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | ||||||||
Cash Fr. Inv. | |||||||||||
Cash Fr. Finan. | 0 | ||||||||||
Net Change | 0 | 0 | |||||||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Wed, 27 Mar 2024
Closure of Trading Window Closure of Trading Window for Insiders of the Company |
Sat, 23 Mar 2024
Announcement under Regulation 30 (LODR)-Allotment Allotment of 2907500 equity shares pursuant to excercise of warrants allotted on preferential basis |
Thu, 21 Mar 2024
Announcement under Regulation 30 (LODR)-Preferential Issue Revised outcome for allotment of warrants of Face Value of Rs. 10.00 on preferential issue basis |
Wed, 27 Mar 2024 |
Opening at High |
Closing Below Previous Low |
Closing Below Previous Low for 3 days |
Making Lower Lows for 3 days |
Close Below Last Week Low |